214 related articles for article (PubMed ID: 19139164)
1. Saturation of multidrug-resistant protein 2 (mrp2/abcc2)-mediated hepatobiliary secretion: nonlinear pharmacokinetics of a heterocyclic compound in rats after intravenous bolus administration.
Hu Y; Sampson KE; Heyde BR; Mandrell KM; Li N; Zutshi A; Lai Y
Drug Metab Dispos; 2009 Apr; 37(4):841-6. PubMed ID: 19139164
[TBL] [Abstract][Full Text] [Related]
2. Quantitative time-lapse imaging-based analysis of drug-drug interaction mediated by hepatobiliary transporter, multidrug resistance-associated protein 2, in sandwich-cultured rat hepatocytes.
Nakanishi T; Shibue Y; Fukuyama Y; Yoshida K; Fukuda H; Shirasaka Y; Tamai I
Drug Metab Dispos; 2011 Jun; 39(6):984-91. PubMed ID: 21415249
[TBL] [Abstract][Full Text] [Related]
3. Two branched polar groups and polar linker moieties of thiophene amide derivatives are essential for MRP2/ABCC2 recognition.
Hu Y; Sampson KE; Xing L; Li N; Heyde BR; Xie J; Lai Y
Drug Metab Lett; 2010 Dec; 4(4):254-61. PubMed ID: 20738239
[TBL] [Abstract][Full Text] [Related]
4. Role of transporters in the disposition of the selective phosphodiesterase-4 inhibitor (+)-2-[4-({[2-(benzo[1,3]dioxol-5-yloxy)-pyridine-3-carbonyl]-amino}-methyl)-3-fluoro-phenoxy]-propionic acid in rat and human.
Kalgutkar AS; Feng B; Nguyen HT; Frederick KS; Campbell SD; Hatch HL; Bi YA; Kazolias DC; Davidson RE; Mireles RJ; Duignan DB; Choo EF; Zhao SX
Drug Metab Dispos; 2007 Nov; 35(11):2111-8. PubMed ID: 17686907
[TBL] [Abstract][Full Text] [Related]
5. Fasiglifam (TAK-875) Inhibits Hepatobiliary Transporters: A Possible Factor Contributing to Fasiglifam-Induced Liver Injury.
Li X; Zhong K; Guo Z; Zhong D; Chen X
Drug Metab Dispos; 2015 Nov; 43(11):1751-9. PubMed ID: 26276582
[TBL] [Abstract][Full Text] [Related]
6. Estimation of transporters involved in the hepatobiliary transport of TA-0201CA using sandwich-cultured rat hepatocytes from normal and multidrug resistance-associated protein 2-deficient rats.
Fukuda H; Ohashi R; Ohashi N; Yabuuchi H; Tamai I
Drug Metab Dispos; 2010 Sep; 38(9):1505-13. PubMed ID: 20538722
[TBL] [Abstract][Full Text] [Related]
7. Improved extrapolation of hepatobiliary clearance from in vitro sandwich cultured rat hepatocytes through absolute quantification of hepatobiliary transporters.
Li N; Singh P; Mandrell KM; Lai Y
Mol Pharm; 2010 Jun; 7(3):630-41. PubMed ID: 20438085
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of Oatp and Mrp2 activities in hepatobiliary excretion using newly developed positron emission tomography tracer [11C]dehydropravastatin in rats.
Shingaki T; Takashima T; Ijuin R; Zhang X; Onoue T; Katayama Y; Okauchi T; Hayashinaka E; Cui Y; Wada Y; Suzuki M; Maeda K; Kusuhara H; Sugiyama Y; Watanabe Y
J Pharmacol Exp Ther; 2013 Oct; 347(1):193-202. PubMed ID: 23926287
[TBL] [Abstract][Full Text] [Related]
9. Identification of the transporters involved in the hepatobiliary transport and intestinal efflux of methyl 1-(3,4-dimethoxyphenyl)-3-(3-ethylvaleryl)-4-hydroxy-6,7,8-trimethoxy-2-naphthoate (S-8921) glucuronide, a pharmacologically active metabolite of S-8921.
Sakamoto S; Kusuhara H; Horie K; Takahashi K; Baba T; Ishizaki J; Sugiyama Y
Drug Metab Dispos; 2008 Aug; 36(8):1553-61. PubMed ID: 18474677
[TBL] [Abstract][Full Text] [Related]
10. Involvement of BCRP (ABCG2) in the biliary excretion of pitavastatin.
Hirano M; Maeda K; Matsushima S; Nozaki Y; Kusuhara H; Sugiyama Y
Mol Pharmacol; 2005 Sep; 68(3):800-7. PubMed ID: 15955871
[TBL] [Abstract][Full Text] [Related]
11. Structure-activity relationships for interaction with multidrug resistance protein 2 (ABCC2/MRP2): the role of torsion angle for a series of biphenyl-substituted heterocycles.
Lai Y; Xing L; Poda GI; Hu Y
Drug Metab Dispos; 2007 Jun; 35(6):937-45. PubMed ID: 17371800
[TBL] [Abstract][Full Text] [Related]
12. Identification of interspecies difference in efflux transporters of hepatocytes from dog, rat, monkey and human.
Li M; Yuan H; Li N; Song G; Zheng Y; Baratta M; Hua F; Thurston A; Wang J; Lai Y
Eur J Pharm Sci; 2008 Sep; 35(1-2):114-26. PubMed ID: 18639632
[TBL] [Abstract][Full Text] [Related]
13. Hepatobiliary disposition of thyroid hormone in Mrp2-deficient TR- rats: reduced biliary excretion of thyroxine glucuronide does not prevent xenobiotic-induced hypothyroidism.
Lecureux L; Dieter MZ; Nelson DM; Watson L; Wong H; Gemzik B; Klaassen CD; Lehman-McKeeman LD
Toxicol Sci; 2009 Apr; 108(2):482-91. PubMed ID: 19211616
[TBL] [Abstract][Full Text] [Related]
14. Involvement of Mrp2 (Abcc2) in biliary excretion of moxifloxacin and its metabolites in the isolated perfused rat liver.
Ahmed S; Vo NT; Thalhammer T; Thalhammer F; Gattringer KB; Jäger W
J Pharm Pharmacol; 2008 Jan; 60(1):55-62. PubMed ID: 18088505
[TBL] [Abstract][Full Text] [Related]
15. Quantitative expression profile of hepatobiliary transporters in sandwich cultured rat and human hepatocytes.
Li N; Bi YA; Duignan DB; Lai Y
Mol Pharm; 2009; 6(4):1180-9. PubMed ID: 19545175
[TBL] [Abstract][Full Text] [Related]
16. Characterization of arsenic hepatobiliary transport using sandwich-cultured human hepatocytes.
Roggenbeck BA; Carew MW; Charrois GJ; Douglas DN; Kneteman NM; Lu X; Le XC; Leslie EM
Toxicol Sci; 2015 Jun; 145(2):307-20. PubMed ID: 25752797
[TBL] [Abstract][Full Text] [Related]
17. Identification of the hepatic efflux transporters of organic anions using double-transfected Madin-Darby canine kidney II cells expressing human organic anion-transporting polypeptide 1B1 (OATP1B1)/multidrug resistance-associated protein 2, OATP1B1/multidrug resistance 1, and OATP1B1/breast cancer resistance protein.
Matsushima S; Maeda K; Kondo C; Hirano M; Sasaki M; Suzuki H; Sugiyama Y
J Pharmacol Exp Ther; 2005 Sep; 314(3):1059-67. PubMed ID: 15901800
[TBL] [Abstract][Full Text] [Related]
18. Localization of P-gp (Abcb1) and Mrp2 (Abcc2) in freshly isolated rat hepatocytes.
Bow DA; Perry JL; Miller DS; Pritchard JB; Brouwer KL
Drug Metab Dispos; 2008 Jan; 36(1):198-202. PubMed ID: 17954525
[TBL] [Abstract][Full Text] [Related]
19. Prediction of in vivo rat biliary drug clearance from an in vitro hepatocyte efflux model.
Lundquist P; Lööf J; Fagerholm U; Sjögren I; Johansson J; Briem S; Hoogstraate J; Afzelius L; Andersson TB
Drug Metab Dispos; 2014 Mar; 42(3):459-68. PubMed ID: 24396143
[TBL] [Abstract][Full Text] [Related]
20. Drug interaction between sunitinib and cimetidine and contribution of the efflux transporter ATP-binding cassette C2 to biliary excretion of sunitinib in rats.
Arakawa-Todo M; Ueyama J; Nomura H; Abe F; Tsukiyama I; Matsuura K; Hasegawa T
Anticancer Res; 2013 Aug; 33(8):3105-11. PubMed ID: 23898066
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]